INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 176 filers reported holding INSMED INC in Q2 2019. The put-call ratio across all filers is 1.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $19,104,000 | +21.7% | 800,000 | -10.1% | 0.60% | -3.5% |
Q3 2019 | $15,700,000 | -31.1% | 890,000 | 0.0% | 0.63% | -24.0% |
Q2 2019 | $22,784,000 | -7.8% | 890,000 | +4.7% | 0.82% | -13.5% |
Q1 2019 | $24,710,000 | +121.6% | 850,000 | 0.0% | 0.95% | +81.2% |
Q4 2018 | $11,152,000 | -38.0% | 850,000 | -4.5% | 0.53% | -19.3% |
Q3 2018 | $17,996,000 | -7.8% | 890,000 | +7.9% | 0.65% | -13.2% |
Q2 2018 | $19,511,000 | +5.0% | 825,000 | 0.0% | 0.75% | -5.3% |
Q1 2018 | $18,579,000 | -2.9% | 825,000 | +34.5% | 0.79% | -8.6% |
Q4 2017 | $19,129,000 | -5.7% | 613,500 | -5.6% | 0.87% | -7.3% |
Q3 2017 | $20,287,000 | +152.6% | 650,000 | +38.9% | 0.94% | +130.5% |
Q2 2017 | $8,031,000 | -2.0% | 468,000 | 0.0% | 0.41% | -14.2% |
Q1 2017 | $8,195,000 | +32.3% | 468,000 | 0.0% | 0.47% | +14.3% |
Q4 2016 | $6,192,000 | -15.2% | 468,000 | -7.0% | 0.41% | -9.6% |
Q3 2016 | $7,304,000 | +48.9% | 503,000 | +1.1% | 0.46% | +26.2% |
Q2 2016 | $4,905,000 | -14.0% | 497,500 | +10.6% | 0.36% | -24.1% |
Q1 2016 | $5,702,000 | -27.4% | 450,000 | +4.0% | 0.48% | -19.7% |
Q4 2015 | $7,850,000 | +15.8% | 432,500 | +18.5% | 0.60% | +8.2% |
Q3 2015 | $6,778,000 | -24.0% | 365,000 | 0.0% | 0.55% | -15.5% |
Q2 2015 | $8,913,000 | +17.4% | 365,000 | 0.0% | 0.65% | -8.3% |
Q1 2015 | $7,592,000 | – | 365,000 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |